THE QUICK READ

Who is Geetha Manjunath?

Geetha Manjunath founded NIRAMAI after a research career that included HP Labs and Xerox. The company works on AI-assisted thermal-imaging technology for breast screening. This founder story examines the transition from technical research to a healthcare product that must function within a clinical workflow.

Founder profiled
Geetha Manjunath
Company or institution
NIRAMAI
Reading lens
Science & health

Source starting point: NIRAMAI: Geetha Manjunath’s research and founder biography ↗. Full sources and context appear below.

Geetha Manjunath brought a research career to entrepreneurship. Her NIRAMAI biography records work at Hewlett Packard Labs and leadership of AI research at Xerox, along with a doctorate from the Indian Institute of Science. The venture applies thermal imaging and artificial intelligence to breast-health screening.

A new setting changes the questions

Moving a technology into healthcare involves more than demonstrating that an algorithm can process an image. The intended use, quality of evidence, practical workflow and people interpreting results become central. A laboratory capability and an appropriate clinical service are connected through substantial work, not a single launch announcement.

The claim must match the evidence

NIRAMAI’s own materials describe its screening approach and ambitions. This profile does not independently establish diagnostic performance or recommend replacing established screening or clinical assessment. The company-building point is that scientific communication must distinguish the proposed use from the outcomes that have actually been evaluated.

The founder lens

Our interpretation of Manjunath’s journey is to identify the new disciplines a technical founder must bring into the team. The original expertise remains important, but the setting demands additional judgement. A credible venture explains both its capability and the evidence needed to use that capability responsibly.

Keep the claim close to the evidence

An AI demonstration and a service used in healthcare answer different questions. A founder’s narrative should explain what the technology is intended to do, what evidence is being discussed and which professional responsibilities surround it. Broad claims can hide differences between a laboratory result and use in a particular setting. For an editorial reader, the useful approach is to follow the chain from a technical idea to the people interpreting and acting on its output. That reveals where collaboration, evaluation and communication are necessary. The founder’s research background helps explain the venture’s starting capabilities; it does not by itself establish the performance of every application.

The decision and its trade-offs

A research result and a healthcare deployment answer different questions. A founder needs to understand not only whether an approach can produce a useful signal, but how data is collected, how results are interpreted and what happens next. The surrounding workflow, professional oversight and quality controls are part of the product’s practical meaning.

How to investigate the operating model

Map the roles of the person being screened, the operator and the clinician. Identify the conditions under which data is collected and the process for handling an uncertain result. Keep research evidence, regulatory status and deployment experience separate when describing progress. A demonstration or award cannot substitute for validation appropriate to the product’s intended use.

Evidence and context

This profile makes no claim about diagnostic accuracy, clinical superiority or suitability for an individual. Screening technologies require assessment in their intended setting; readers should consult qualified healthcare professionals for medical decisions.

YOUR WORKING NOTES

Put the idea to work

Use these questions to investigate the idea in your own context.

  1. State the intended use before describing a technical result.
  2. Separate a research milestone from a claim about real-world outcomes.
  3. Identify the people and processes surrounding the technology’s use.

A closer look

What changes when an AI idea moves into a healthcare setting?

The team must consider the intended use, the evidence relevant to it, the surrounding workflow and the people interpreting results. NIRAMAI’s founder story makes those development questions visible; a technical demonstration alone does not answer every question about use in practice.

What should a founder investigate in the NIRAMAI story?

Ask which claims are supported by published studies, what population and setting they concern and how the product fits into professional care.

Sources & editorial note

This profile draws on the public sources below. Company and founder accounts describe their own perspective. Our analysis, questions and takeaway are editorial interpretation. This is not an original interview or a sponsored feature.

See our editorial standards or request a correction. For a useful comparison, read Kiran Mazumdar-Shaw: the Biocon founder story. Explore the founder topic guides for connected reading paths.